1. Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
   Meng-Ying Cui et al, 2022, Journal of Oncology CrossRef
2. Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
   Linyuan Xue et al, 2020, Frontiers in Oncology CrossRef
3. SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway
   Jing Zhao et al, 2020, Cell Death & Disease CrossRef
4. Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
   Isabella Giacomini et al, 2021, Frontiers in Oncology CrossRef
5. Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma
   Liang Li et al, 2021, International Journal of General Medicine CrossRef
6. The role of cholesterol metabolism in tumor therapy, from bench to bed
   Wenhao Xia et al, 2023, Frontiers in Pharmacology CrossRef